Cargando…
Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy
Approximately 1 in 2500 Americans suffer from Charcot-Marie-Tooth (CMT) disease. The underlying disease mechanisms are unique in most forms of CMT, with many point mutations on various genes causing a toxic accumulation of misfolded proteins. Symptoms of the disease often present within the first tw...
Autores principales: | Sames, Lori, Moore, Allison, Arnold, Renee, Ekins, Sean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023663/ https://www.ncbi.nlm.nih.gov/pubmed/24860645 http://dx.doi.org/10.12688/f1000research.3751.2 |
Ejemplares similares
-
Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies
por: Stavrou, Marina, et al.
Publicado: (2021) -
Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development
por: Juneja, Manisha, et al.
Publicado: (2019) -
The cerebellar phenotype of Charcot-Marie-Tooth neuropathy type 4C
por: Skott, Humberto, et al.
Publicado: (2019) -
Efficacy of exogenous pyruvate in Trembler(J) mouse model of Charcot‐Marie‐Tooth neuropathy
por: Sahenk, Zarife, et al.
Publicado: (2018) -
Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy
por: Mo, Zhongying, et al.
Publicado: (2018)